# FDA 483 - Avista Pharma Solutions, Inc. dba Cambrex - July 25, 2025

Source: https://www.globalkeysolutions.net/records/483/avista-pharma-solutions-inc-dba-cambrex/9114de19-b62a-4740-b343-34d5774c7c21

> FDA 483 for Avista Pharma Solutions, Inc. dba Cambrex on July 25, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Avista Pharma Solutions, Inc. dba Cambrex
- Inspection Date: 2025-07-25
- Product Type: drugs

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/avista-pharma-solutions-inc-dba-cambrex/4500de12-8c31-48c9-bcda-71036d2c9088)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/avista-pharma-solutions-inc-dba-cambrex/f9656301-6020-42e7-b2b3-737a91b254ed)

## Related Officers

- [M.S., Consumer Safety Officer at FDA](https://www.globalkeysolutions.net/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [investigator](https://www.globalkeysolutions.net/people/ifechimere-i-okafor/c48399bf-47d9-4562-9130-1e6731eca07d)

Company: https://www.globalkeysolutions.net/companies/avista-pharma-solutions-inc-dba-cambrex/abe58c04-c144-4601-a4df-a290928bafa5